CLOVER BIOPHARMACEUTICALS LTD financial statements, including revenue, expenses, and profit
The total revenue of 2197 for the last semiannual is 52.63 M HKD, and it's 580.91% higher compared to the previous semiannual. The net income of H2 24 is -876.86 M HKD.